Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.499,75
-0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lucid Diagnostics Inc (LUCD) Lucid Diagnostics Inc (LUCD) Notizie

Lucid Diagnostics Inc

LUCD
1,06
0,1303 (14,02%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:02:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:35PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
02/5/202413:49PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
29/4/202414:47PRNUSLucid Diagnostics Partners with the Esophageal Cancer Action..
08/4/202414:30PRNUSLucid Diagnostics to Participate in Fireside Chat at the..
27/3/202400:32PRNUSPAVmed Provides Business Update and Fourth Quarter and Full..
25/3/202422:30PRNUSLucid Diagnostics Provides Business Update and Preliminary..
21/3/202414:30PRNUSLucid Diagnostics Announces Positive Data from the First..
20/3/202413:30PRNUSLucid Diagnostics Announces Multiple Presentations at the..
12/3/202413:30PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
23/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00PRNUSLucid Diagnostics Provides Update Regarding World Trade..
15/2/202413:45PRNUSLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog,..
08/2/202413:45PRNUSLucid Diagnostics Executes Contract to Provide EsoGuard®..
06/2/202423:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/2/202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202423:00EDGAR2Form 8-K - Current report
12/12/202314:30PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
11/12/202315:00PRNUSPAVmed Provides Additional Details for Upcoming Stock..
04/12/202322:20PRNUSPAVmed Announces Dividend of Lucid Diagnostics Common Stock..
28/11/202322:30EDGAR2Form 8-K - Current report
24/11/202322:05EDGAR2Form 8-K - Current report
16/11/202315:00PRNUSLucid Diagnostics Strengthens and Expands Market Access and..
14/11/202323:43PRNUSPAVmed Provides Business Update and Third Quarter Financial..
14/11/202303:40EDGAR2Form 8-K - Current report
13/11/202323:40PRNUSLucid Diagnostics Provides Business Update and Third Quarter..
13/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:35EDGAR2Form 8-K - Current report
09/11/202315:00PRNUSLucid Diagnostics Launches Next-Generation EsoGuard®..
02/11/202314:18PRNUSLucid Diagnostics to Present at Canaccord Genuity Medtech,..
01/11/202321:21EDGAR2Form D - Notice of Exempt Offering of Securities
01/11/202314:10PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
31/10/202314:00PRNUSLucid Diagnostics Announces PREVENT and PREVENT-FF..
31/10/202313:55PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
18/10/202315:15EDGAR2Form 8-K - Current report
21/9/202314:30PRNUSPAVmed and Lucid Diagnostics to Participate in Panel..
07/9/202315:26PRNUSLucid Diagnostics Releases Positive Data from First..
06/9/202315:00PRNUSLucid Diagnostics Releases Positive Data Demonstrating..
24/8/202315:00PRNUSLucid Diagnostics Executes First Direct Employer Contract to..
16/8/202302:17PRNUSPAVmed Provides Business Update and Second Quarter Financial..
15/8/202300:48PRNUSLucid Diagnostics Provides Business Update and Second..
14/8/202322:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202300:19PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
01/8/202300:00PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
26/7/202314:30PRNUSLucid Diagnostics to Present at the Canaccord Genuity 43rd..
19/7/202315:04PRNUSPAVmed and Lucid Chairman and Chief Executive Officer, Dr...
28/6/202322:05PRNUSPAVmed Receives 180-Day Extension to Regain Compliance with..
14/6/202322:05PRNUSPAVmed to Participate in Healthcare Virtual Conference..
05/6/202313:00PRNUSLucid Diagnostics Launches First EsoGuard® Mobile Test Unit
02/6/202313:00PRNUSPAVmed Digital Health Subsidiary, Veris Health, Joins Cancer..
16/5/202323:00PRNUSPAVmed Provides Business Update and First Quarter Financial..
Apertura: 0,96 Min: 0,94 Max: 1,07
Chiusura: 0,9297

La tua Cronologia

NASDAQ
LUCD
Lucid Diagnostics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network